Logo image of WAY

WAYSTAR HOLDING CORP (WAY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:WAY - US9467841055 - Common Stock

36.84 USD
-0.2 (-0.54%)
Last: 11/28/2025, 12:33:54 PM
Fundamental Rating

6

WAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. WAY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. WAY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year WAY was profitable.
In the past year WAY had a positive cash flow from operations.
WAY Yearly Net Income VS EBIT VS OCF VS FCFWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.34%, WAY belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
WAY has a Return On Equity of 3.45%. This is amongst the best in the industry. WAY outperforms 82.86% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.19%, WAY is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for WAY is below the industry average of 6.67%.
The 3 year average ROIC (2.09%) for WAY is below the current ROIC(4.19%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.34%
ROE 3.45%
ROIC 4.19%
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
WAY Yearly ROA, ROE, ROICWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 1 -1 2 -2

1.3 Margins

Looking at the Profit Margin, with a value of 10.69%, WAY belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
Looking at the Operating Margin, with a value of 23.41%, WAY belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
In the last couple of years the Operating Margin of WAY has grown nicely.
WAY's Gross Margin of 67.78% is fine compared to the rest of the industry. WAY outperforms 68.57% of its industry peers.
In the last couple of years the Gross Margin of WAY has declined.
Industry RankSector Rank
OM 23.41%
PM (TTM) 10.69%
GM 67.78%
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
WAY Yearly Profit, Operating, Gross MarginsWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WAY is destroying value.
WAY has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, WAY has an improved debt to assets ratio.
WAY Yearly Shares OutstandingWAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
WAY Yearly Total Debt VS Total AssetsWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

WAY has an Altman-Z score of 3.25. This indicates that WAY is financially healthy and has little risk of bankruptcy at the moment.
WAY's Altman-Z score of 3.25 is fine compared to the rest of the industry. WAY outperforms 71.43% of its industry peers.
WAY has a debt to FCF ratio of 4.35. This is a neutral value as WAY would need 4.35 years to pay back of all of its debts.
WAY has a better Debt to FCF ratio (4.35) than 65.71% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that WAY is not too dependend on debt financing.
WAY's Debt to Equity ratio of 0.38 is on the low side compared to the rest of the industry. WAY is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.35
Altman-Z 3.25
ROIC/WACC0.42
WACC9.87%
WAY Yearly LT Debt VS Equity VS FCFWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

WAY has a Current Ratio of 3.89. This indicates that WAY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.89, WAY belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
WAY has a Quick Ratio of 3.89. This indicates that WAY is financially healthy and has no problem in meeting its short term obligations.
WAY has a better Quick ratio (3.89) than 82.86% of its industry peers.
Industry RankSector Rank
Current Ratio 3.89
Quick Ratio 3.89
WAY Yearly Current Assets VS Current LiabilitesWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 272.54% over the past year.
Looking at the last year, WAY shows a quite strong growth in Revenue. The Revenue has grown by 14.75% in the last year.
Measured over the past years, WAY shows a quite strong growth in Revenue. The Revenue has been growing by 17.71% on average per year.
EPS 1Y (TTM)272.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%164.29%
Revenue 1Y (TTM)14.75%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%11.89%

3.2 Future

The Earnings Per Share is expected to grow by 52.32% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.62% on average over the next years. This is quite good.
EPS Next Y356.57%
EPS Next 2Y126.79%
EPS Next 3Y79.29%
EPS Next 5Y52.32%
Revenue Next Year15.62%
Revenue Next 2Y15.9%
Revenue Next 3Y14.19%
Revenue Next 5Y12.62%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
WAY Yearly Revenue VS EstimatesWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
WAY Yearly EPS VS EstimatesWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.49, the valuation of WAY can be described as expensive.
Based on the Price/Earnings ratio, WAY is valued a bit cheaper than 80.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.15, WAY is valued at the same level.
Based on the Price/Forward Earnings ratio of 22.59, the valuation of WAY can be described as rather expensive.
WAY's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. WAY is cheaper than 74.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of WAY to the average of the S&P500 Index (36.12), we can say WAY is valued slightly cheaper.
Industry RankSector Rank
PE 27.49
Fwd PE 22.59
WAY Price Earnings VS Forward Price EarningsWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

71.43% of the companies in the same industry are more expensive than WAY, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, WAY is valued a bit cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.72
EV/EBITDA 20.67
WAY Per share dataWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

WAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WAY has a very decent profitability rating, which may justify a higher PE ratio.
WAY's earnings are expected to grow with 79.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y126.79%
EPS Next 3Y79.29%

0

5. Dividend

5.1 Amount

No dividends for WAY!.
Industry RankSector Rank
Dividend Yield N/A

WAYSTAR HOLDING CORP

NASDAQ:WAY (11/28/2025, 12:33:54 PM)

36.84

-0.2 (-0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-16 2026-02-16
Inst Owners69.9%
Inst Owner Change29.32%
Ins Owners1.26%
Ins Owner Change-0.38%
Market Cap7.03B
Revenue(TTM)1.04B
Net Income(TTM)111.18M
Analysts85.71
Price Target50.52 (37.13%)
Short Float %6.36%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.35%
Min EPS beat(2)4.39%
Max EPS beat(2)6.31%
EPS beat(4)3
Avg EPS beat(4)28.35%
Min EPS beat(4)-1.27%
Max EPS beat(4)103.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.78%
Min Revenue beat(2)3.6%
Max Revenue beat(2)3.95%
Revenue beat(4)4
Avg Revenue beat(4)3.51%
Min Revenue beat(4)2.36%
Max Revenue beat(4)4.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.23%
PT rev (3m)-1.43%
EPS NQ rev (1m)12.95%
EPS NQ rev (3m)13.47%
EPS NY rev (1m)2.91%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)10.98%
Revenue NQ rev (3m)13.68%
Revenue NY rev (1m)2.93%
Revenue NY rev (3m)3.72%
Valuation
Industry RankSector Rank
PE 27.49
Fwd PE 22.59
P/S 6.76
P/FCF 24.72
P/OCF 22.85
P/B 2.18
P/tB N/A
EV/EBITDA 20.67
EPS(TTM)1.34
EY3.64%
EPS(NY)1.63
Fwd EY4.43%
FCF(TTM)1.49
FCFY4.05%
OCF(TTM)1.61
OCFY4.38%
SpS5.45
BVpS16.88
TBVpS-3.94
PEG (NY)0.08
PEG (5Y)N/A
Graham Number22.56
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.45%
ROCE 5.3%
ROIC 4.19%
ROICexc 4.61%
ROICexgc 99.81%
OM 23.41%
PM (TTM) 10.69%
GM 67.78%
FCFM 27.36%
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
ROICexc(3y)2.13%
ROICexc(5y)N/A
ROICexgc(3y)47.51%
ROICexgc(5y)N/A
ROCE(3y)2.64%
ROCE(5y)N/A
ROICexgc growth 3Y7.56%
ROICexgc growth 5YN/A
ROICexc growth 3Y30.65%
ROICexc growth 5YN/A
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
F-Score8
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.35
Debt/EBITDA 3.21
Cap/Depr 16.87%
Cap/Sales 2.24%
Interest Coverage 250
Cash Conversion 80.68%
Profit Quality 255.91%
Current Ratio 3.89
Quick Ratio 3.89
Altman-Z 3.25
F-Score8
WACC9.87%
ROIC/WACC0.42
Cap/Depr(3y)12.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)272.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%164.29%
EPS Next Y356.57%
EPS Next 2Y126.79%
EPS Next 3Y79.29%
EPS Next 5Y52.32%
Revenue 1Y (TTM)14.75%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%11.89%
Revenue Next Year15.62%
Revenue Next 2Y15.9%
Revenue Next 3Y14.19%
Revenue Next 5Y12.62%
EBIT growth 1Y124.84%
EBIT growth 3Y27.06%
EBIT growth 5YN/A
EBIT Next Year134.75%
EBIT Next 3Y42.44%
EBIT Next 5Y31.56%
FCF growth 1Y375.9%
FCF growth 3Y15.76%
FCF growth 5YN/A
OCF growth 1Y229.9%
OCF growth 3Y16.85%
OCF growth 5YN/A

WAYSTAR HOLDING CORP / WAY FAQ

What is the fundamental rating for WAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to WAY.


What is the valuation status for WAY stock?

ChartMill assigns a valuation rating of 6 / 10 to WAYSTAR HOLDING CORP (WAY). This can be considered as Fairly Valued.


Can you provide the profitability details for WAYSTAR HOLDING CORP?

WAYSTAR HOLDING CORP (WAY) has a profitability rating of 6 / 10.


What is the financial health of WAYSTAR HOLDING CORP (WAY) stock?

The financial health rating of WAYSTAR HOLDING CORP (WAY) is 7 / 10.